Zomedica ZOMDF
OTC ZOMDF
$0.08 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zomedica (ZOMDF) Non Operating Interest Expenses (2019 - 2023)

Analysis

Zomedica (ZOMDF) Non Operating Interest Expenses (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Zomedica 78.40 Mn -119.63 Mn 6.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 64,000.00
Jun 30, 2023 62,000.00
Mar 31, 2023 50,000.00
Dec 31, 2021 -54.00
Jun 30, 2021 6,054.00
Mar 31, 2020 651.00
Jun 30, 2019 12,164.00
Mar 31, 2019 6,174.00
API Access

Zomedica Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY